• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    3.54 Down 0.01(0.28%) Mar 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.55
    Open:3.56
    Bid:N/A
    Ask:8.00 x 100
    1y Target Est:16.00
    Beta:1.64
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:3.50 - 3.73
    52wk Range:3.00 - 17.14
    Volume:63,423
    Avg Vol (3m):278,747
    Market Cap:83.35M
    P/E (ttm):N/A
    EPS (ttm):-0.78
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GALT

    Comparison

    Symbol% ChgMkt Cap
    GALTDown 0.28%83.35M
    MNTAUp 1.76%803.41M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.76
    Quarterly EPS Est (Mar-15) :-0.20
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic disease and cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback